Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study.
Frangos S, Iakovou IP, Marlowe RJ, Eftychiou N, Patsali L, Vanezi A, Savva A, Mpalaris V, Giannoula EI. Frangos S, et al. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2045-55. doi: 10.1007/s00259-015-3124-4. Epub 2015 Aug 1. Eur J Nucl Med Mol Imaging. 2015. PMID: 26231351
Erratum to: Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study.
Frangos S, Iakovou IP, Marlowe RJ, Eftychiou N, Patsali L, Vanezi A, Savva A, Mpalaris V, Giannoula EI. Frangos S, et al. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):206-207. doi: 10.1007/s00259-015-3238-8. Eur J Nucl Med Mol Imaging. 2016. PMID: 26526594 No abstract available.
Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.
Verburg FA, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Luster M; EANM and the EANM Thyroid Committee. Verburg FA, et al. Among authors: frangos s. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1001-5. doi: 10.1007/s00259-016-3327-3. Epub 2016 Feb 17. Eur J Nucl Med Mol Imaging. 2016. PMID: 26883666 No abstract available.
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.
Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, Iakovou I, Mihailovic J, Krause BJ, Langsteger W, Verburg FA, Luster M; EANM and the EANM Thyroid Committee. Treglia G, et al. Among authors: frangos s. Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90. doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27. Eur J Nucl Med Mol Imaging. 2016. PMID: 27118126 No abstract available.
Why should we be concerned about a "g"?
Frangos S, Buscombe JR. Frangos S, et al. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):519. doi: 10.1007/s00259-018-4204-z. Epub 2018 Nov 6. Eur J Nucl Med Mol Imaging. 2019. PMID: 30402792 No abstract available.
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma.
Dizdarevic S, Tulchinsky M, McCready VR, Mihailovic J, Vinjamuri S, Buscombe JR, Lee ST, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I; WARMTH Thyroid Group. Dizdarevic S, et al. Among authors: frangos s. World J Nucl Med. 2019 Apr-Jun;18(2):123-126. doi: 10.4103/wjnm.WJNM_117_18. World J Nucl Med. 2019. PMID: 31040741 Free PMC article. No abstract available.
168 results